chlorthalidone has been researched along with pargyline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moyer, JH; Onesti, G | 1 |
| Brest, AN; Kim, KE; Onesti, G; Schwartz, AB; Swartz, C | 1 |
| MIZGALA, HF | 1 |
1 review(s) available for chlorthalidone and pargyline
| Article | Year |
|---|---|
NEWER DRUGS IN THE TREATMENT OF HYPERTENSION.
Topics: Antihypertensive Agents; Bretylium Compounds; Chlorothiazide; Chlorthalidone; Diuretics; Drug Therapy; Essential Hypertension; Guanethidine; Hydralazine; Hypertension; Methyldopa; Pargyline; Rauwolfia; Spironolactone; Toxicology | 1965 |
2 other study(ies) available for chlorthalidone and pargyline
| Article | Year |
|---|---|
Hypertension past 60.
Topics: Aged; Benzothiadiazines; Chlorthalidone; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Pargyline; Phytotherapy; Plants, Medicinal; Rauwolfia; Reserpine | 1967 |
Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155).
Topics: Antihypertensive Agents; Blood Pressure; Cardiac Output; Cardiovascular System; Chlorthalidone; Dye Dilution Technique; Glomerular Filtration Rate; Guanethidine; Hemodynamics; Humans; Hypertension; Imidazoles; Kidney; Methyldopa; Pargyline; Posture; Sodium Chloride; Time Factors; Vascular Resistance | 1969 |